Dr. Elena Aikawa is an Associate Professor of Medicine at Harvard Medical School and the founding Director of the Heart Valve Translational Research Program at Brigham and Women’s Hospital (BWH).
Dr. Aikawa’s primary research emphasis is on the development of new therapies to prevent and treat calcific aortic valve stenosis, a disease that currently has no treatment options except invasive valve replacement. She was at the forefront of molecular imaging of cardiac valve calcification, and has advocated for the early imaging and treatment of calcific aortic valve disease. Her recent studies focus on the formation of extracellular vesicle-derived microcalcifications in cardiovascular system.
Dr. Aikawa is a member of the NHLBI Working Group on Calcific Aortic Valve Stenosis and the Alliance of Investigators on Calcific Aortic Valve Disease. She holds editorial board member positions at PLoS ONE, Journal of Extracellular Vesicles, Circulation Research and Arteriosclerosis, Thrombosis and Vascular Biology. Dr. Aikawa has delivered more than 120 keynote lectures and cardiovascular grand rounds in US and around the world. She has published 170 reports on cardiovascular pathobiology and applied for eight patents.
Dr. Aikawa remains committed to advancing the careers of women in science and medicine. She co-founded the BWH Committee for Internationally Trained Women Faculty in 2004, and established the Women in Medicine and Science Symposium at BWH in 2012. Dr. Aikawa is a member of the AHA Council on Arteriosclerosis, Thrombosis and Vascular Biology Women’s Leadership Committee. She is a president of the International Society for Applied Cardiovascular Biology (ISACB).